About Us:
Zealand Pharma is a biotechnology company focused on advancing medicines for obesity and metabolic health, including rare diseases like congenital hyperinsulinism. With more than 25 years of peptide R&D expertise and a proprietary data platform leveraging advanced data driven and AI/ML approaches, we aim to lead a new era in metabolic health.
More than ten Zealand Pharma invented drug candidates have entered clinical development, of which two products have reached the market and three candidates are in late-stage development. The Company has collaborations with global pharmaceutical and biotechnology partners for research, development, and commercialization.
Founded in 1998, Zealand Pharma is headquartered in Copenhagen, with a U.S. presence in Boston.
Address:
Sydmarken 11
Copenhagen, Denmark 2860
Denmark
Phone:
(458) 877-3600
Email:
Website:
https://www.zealandpharma.com/
Brief summary of content:
Pipeline: https://www.zealandpharma.com/pipeline/
Disease Areas: https://www.zealandpharma.com/disease-areas/
Congenital Hyperinsulinism: https://www.zealandpharma.com/disease-areas/congenital-hyperinsulinism/
Enter the MAP Spotlight Raffle